However, in contrast to MKK3, p38 upregulation does not correlate with decreases survival of Black/African American patients neither for all breast cancer subtypes (p = 0.986) (Fig. 4j) nor specifically for the TNBC (p = 0.193, Fig. 4k). This evidence concerns the gene MAP2K3 and breast carcinoma.